Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Fortress Biotech (FBIO) over the last 13 years, with Q3 2025 value amounting to $181.4 million.

  • Fortress Biotech's Liabilities and Shareholders Equity rose 4274.46% to $181.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $663.6 million, marking a year-over-year increase of 969.6%. This contributed to the annual value of $144.2 million for FY2024, which is 1391.01% down from last year.
  • As of Q3 2025, Fortress Biotech's Liabilities and Shareholders Equity stood at $181.4 million, which was up 4274.46% from $159.9 million recorded in Q2 2025.
  • In the past 5 years, Fortress Biotech's Liabilities and Shareholders Equity registered a high of $418.2 million during Q2 2021, and its lowest value of $127.1 million during Q3 2024.
  • In the last 5 years, Fortress Biotech's Liabilities and Shareholders Equity had a median value of $181.4 million in 2025 and averaged $256.1 million.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first skyrocketed by 7094.1% in 2021, then tumbled by 5347.12% in 2023.
  • Fortress Biotech's Liabilities and Shareholders Equity (Quarter) stood at $396.5 million in 2021, then fell by 25.78% to $294.3 million in 2022, then plummeted by 43.08% to $167.5 million in 2023, then fell by 13.91% to $144.2 million in 2024, then grew by 25.78% to $181.4 million in 2025.
  • Its Liabilities and Shareholders Equity was $181.4 million in Q3 2025, compared to $159.9 million in Q2 2025 and $178.1 million in Q1 2025.